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Meta-analysisa b s t r a c t
Toxoplasmosis is a neglected parasitic disease with global distribution in warm-blooded vertebrates and
high prevalence among different human societies. We contrived a systematic review and meta-analysis
on the prevalence of toxoplasmosis in Iran. Following the general methodology recommended for sys-
tematic reviews and meta-analysis, four English and three Persian electronic databases were explored
up to April 2016. Out of 105,139 examined samples of different hosts, the weighted overall prevalence
was 37% (95% CI = 31–43). Due to the significant heterogeneity (I2 = 81.9%) the random-effects model
was used. The pool estimated prevalence of toxoplasmosis in human intermediate hosts, animal interme-
diate hosts, and definitive hosts was 43% (95% CI = 38–47), 26 (95% CI = 17–35) and, 34% (95% CI = 22–46),
respectively. Our results represent that regular inspection in food industries, improved screening pro-
grams using standard diagnostic assay as well as distinguishing toxoplasmosis condition in other zoono-
tic hosts are extremely recommended for better disease management in Iran.
 2017 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. This is an open
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An obligate intracellular parasitic protozoan, Toxoplasma gondii
(T. gondii), infects approximately one third of the world’s popula-
tion, and causes a potential zoonotic disease called toxoplasmo-
sis.1–3 This infection is appointed to be a neglected parasitic
disease by CDC (Centers for Disease Control and Prevention), char-
acterized by high prevalence and chronic nature as well, which
principally occurs in regions with poor hygiene.4 The majority of
warm-blooded animals as intermediate hosts may be sources of
tissue cysts, universal abundance of felines (Family: Felidae) as
definitive hosts as well as multiple transmission routes have main-
tained parasite dissemination in the environment. T. gondii gains
access to the host’s body through several principal pathways,
including: vertical transmission, oocyst-contaminated food and
water, raw or undercooked meat containing viable tissues cysts,
organ transplantation, and blood transfusion.1,3,5–8 Human popula-
tions are dead-end host for toxoplasmosis with up to 80% suffering
from chronic asymptomatic infection.9 Pregnant women and
immunocompromised individuals (cancer, transplant and AIDS
patients) comprise the two important risk groups for toxoplasmo-
sis.3,5,10,11 Owing to the Toxoplasma predilection to the brain and
eye, poor prognosis and complications such as glaucoma, choriore-
tinitis, retinal detachment, brain abscess and encephalitis can
occur during acute or recrudescent infection.12,13 Furthermore,
serious complications such as brain focal lesions, hydrocephaly,
microcephaly, deafness, and mental retardation may arise from
congenital toxoplasmosis, according to the gestational age.3,6,10
Additionally cerebral toxoplasmosis may have also a significant
correlation to neurodegenerative disorders like schizophrenia, epi-
lepsy, and bipolar disorder.14–17 Moreover, chronic toxoplasmosis
is strongly correlated to autoimmune diseases.18,19 Routine diag-
nostic methods for toxoplasmosis generally pertain to serology-
dependent experiments such as enzyme-linked immunosorbent
assay (ELISA) and indirect immunofluorescence assay (IFA) in order
to discern the T. gondii-specific antibodies, i.e. IgM or IgG.20 In addi-
tion to the medical significance of toxoplasmosis, this protozoan is
of veterinary importance in terms of abortion in sheep herds asIraq
Saudi A
Fig. 1. Location ofwell as a relatively high prevalence in domestic animals in Iran
such as cat, sheep, goat and cattle.21–23
We have designed a systematic review and meta-analysis in
order to shed light on the status of Toxoplasma infection in both
human and animal populations. We hope that the conception
derived from this study help us to better understand the epidemi-
ological surveillance of toxoplasmosis in Iran.
2. Materials and methods
2.1. Study area
Covering a wide area in the Middle East (1,648,195 km2) (Fig. 1),
Iran with population of approximately 80 million in 2015, located
between 2530 and 39470N, and 4450 and 63180E, and bordering
Iraq and Turkey in the west, Afghanistan and Pakistan in the east,
the Persian Gulf and Oman Sea in the south, as well as Azerbaijan,
Armenia and Turkmenistan in the north. Except for a small region
on the margin of the Caspian Sea coast with a considerable annual
rainfall and covered by dense vegetation, the general climate of
Iran is hot and dry, forming the Iranian plateau. It is one of the
world’s most mountainous countries, its landscape dominated by
rugged mountain ranges that separate various basins or plateaux
from each other. The populous western part is the most mountain-
ous, with ranges such as the Caucasus, Zagros and Alborz Moun-
tains. Lower temperatures, severe winters and heavy snowfalls
exist in the Zagros basin, while in the central and eastern basins
there is an arid climate because of high-altitude mountain ranges
in the western and northern parts. These mountain ranges are so
high that rain clouds cannot reach the central and eastern basins.
Annual precipitation is 680 mm in the eastern part of the plain
and more than 1700 mm (66.9 in.) in the western part.24
2.2. Search strategy
In this systematic review and meta-analysis we sought to deter-
mine the epidemiological aspects of toxoplasmosis in both human
and animal population in Iran. The search strategy was performedCaspian Sea
Persian Gulfrabia
Iran country.
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(PubMed, Web of Science, Scopus, and Google Scholar) and three
Persian databases (Scientific Information Database, Iran Medex,
and Magiran) up to April 2016. This review was accomplished
using medical subject heading (MeSH) terms and combination of
several keywords consisting of: ‘‘Toxoplasma”, ‘‘Toxoplasma gondii”,
‘‘Toxoplasmosis”, ‘‘Prevalence”, ‘‘Epidemiology”, ‘‘Iran”, ‘‘Islamic
Republic of Iran”, ‘‘Systematic review”, and ‘‘meta-analysis”.
2.3. Study selection and data extraction
During initial search, the relevant citations were recorded based
on topics and abstracts of them were saved in a world file for next
evaluation. Afterwards, based on primary screening the records
that seem to be potentially eligible were chosen to download the
full-text. The retrieved papers were reviewed precisely by two dif-
ferent reviewers (M. Foroutan and H. Majidiani) to evaluate the
final eligibility and inclusion criteria. The selected articles were
read carefully and incoherence among studies was clarified by con-
troversy and consensus. The required data were extracted by one
author (M. Foroutan) and rechecked by a second (S. Khademvatan).
Inclusion criteria were as follows: (1) systematic review and meta-
analysis papers; (2) review articles that estimated the prevalence
of T. gondii in human or animal population; (3) published online
up to April 2016; (4) published in English or Persian; (5) full-text
articles were available; (6) exact total sample size and positive
samples were available. The papers were excluded if they didn’t
met the above-mentioned criteria. The reference list of selected
full-text articles were also meticulously checked manually to find
papers not retrieved by the database searching. Finally, a data
extraction form was exerted to gather data depending on the study
population, number of included studies, number of examined sam-
ples, duration of time, number of positive cases, prevalence (95%
CI), study methodology, and main findings. The preferred reporting
items for systematic reviews and meta-analysis (PRISMA) guide-
line was used to report our results.25
2.4. Meta-analysis
Meta-analysis procedure was performed as previously
described.24,26,61 Briefly, prevalence and its 95% confidence interval
(CI) of toxoplasmosis were extracted from each included paper.
Then forest plot was drawn to illustrate the meta-analysis out-
comes. Cochran’s Q and I2 statistics were employed to quantify
the variations and heterogeneity. I2 values of 25%, 50% and 75%
were considered as low, moderate and high heterogeneity, respec-
tively.27 Besides, in order to evaluate publication bias and small
study effects, the funnel plot relied on Egger’s regression test was
used. Either Der Simonian and Laird’s random-effects method or
Mantel-Haenszel’s fixed-effects method were used to pool the esti-
mations, based on the results of heterogeneity test. Furthermore,
we divided the papers by different subgroups (human intermedi-
ate host, animal intermediate host, and definitive host) and pool
estimation was calculated for them.3. Results
Herein we summarize the results of the current systematic
review and meta-analysis. According to Supplementary Fig. 1, a
number of 142 studies were explored during literature review,
among which 7 papers were eligible for this systematic review
and meta-analysis based on the inclusion criteria.1–3,5,21–23 Due
to the presence of significant heterogeneity (I2 = 81.9%) the
random-effects model was applied. The Egger’s regression test
was carried out, suggesting that there is no substantial influencefor publication bias on overall prevalence estimate (P = 0.9). Also,
the forest plot diagram of the current meta-analysis has been
depicted in Supplementary Fig. 2. Considering Table 1, the out-
comes of literature search and related features of studies, the num-
ber of included studies, examined samples and positive cases,
prevalence rate and coverage period are shown. The subgroup
analysis in different hosts yielded 43% (95% CI = 38–47) and 26%
(95% CI = 17–35) prevalence rate in human and animal intermedi-
ate hosts, respectively (Table 2). We found that transplant patients
category was the most at-risk group regarding toxoplasmosis in
human hosts with 702 examined samples, 372 positive cases and
a prevalence rate of 55% (95% CI = 43–67). On the contrary, the
least at-risk group was blood donors with a prevalence rate of
33% (95% CI = 24–42). Additionally, the pool estimated prevalence
of toxoplasmosis in definitive hosts was evaluated 34% (95%
CI = 22–46) (Table 2). The most widely-used diagnostic tests to
evaluate Toxoplasma infection in human hosts were as follows:
ELISA in 73 studies and IFA in 40 studies. In animal intermediate
and definitive hosts IFA followed by direct agglutination test
(DAT) were the most common employed experiments (Table 1).4. Discussion
Being one of the marvelous parasites, T. gondii still possesses a
relatively high rate of prevalence in different mankind societies
as well as various animal species.1,3,8,11,21,28–32 The objective of this
systematic review and meta-analysis was to estimate the preva-
lence of T. gondii infection in human and animal populations in Iran
premised on records obtained from literature review. We searched
7 databases among which 7 papers were included with 105,139
examined samples obtained from different hosts and weighted
overall prevalence was 37% (95% CI = 31–43) (Table 2). There have
been multiple risk factors involved in the high prevalence of toxo-
plasmosis in Iran. Suppression of the host immune responses, con-
sumption of oocysts contaminated water and unwashed fruit and
vegetables, keeping cats indoors as pet animals, eating raw meat
and direct contact with meat or viscera of infected animals are
among the risk factors which directly increase the incidence of tox-
oplasmosis.2,3,5,23 Regarding climate, any meteorological agent that
can facilitate the sporulation of Toxoplasma oocysts shed in the cat
feces, e.g. appropriate humidity, would entail the protracted sur-
vival and spread of infective parasites in the environment, and
hence the higher contingency of human and animal infection.23,33
Meanwhile, some risk factors such as occupation, gender, place
of residence, and level of education indirectly influence the
above-mentioned behaviors and bias the prevalence of infection.
Two risk factors, contact with cat and place of residence, have been
significantly correlated to toxoplasmosis in Iranian general popula-
tion as well as pregnant women2,3 (Table 1). Abundance of cats and
infected prey animals as well as high survival of oocysts in dump
soil, high number of rural communities, lack of adequate health lit-
eracy and limited access to health resources, would justify 39%
(95% CI = 33–46) prevalence of T. gondii infection in Iranian general
population.2,23,32 The prevalence is lower in USA, Mexico and
China, being 10.8%, 20.26% and 6.31%, respectively, mostly due to
the good hygienic measures, successful educational programs to
alert people, precise diagnostic tests for women of childbearing
age and pregnant women, industrialization of animal husbandry
as well as well-established monitoring systems and improved rules
in meat inspection.11,34,35 In Ethiopia, toxoplasmosis prevalence
rate of 75% has been observed which may be corroborated by the
abundance of infected cats and food animals, low levels of hygiene
and living in sub-standard conditions.28
Pregnant women are substantial targets of T. gondii infection
and the seroprevalence of infection among this population in Iran
Table 1
Baseline characteristics of included studies.














































Estimated seropositive rate of toxoplasmosis among the different studies has a wide variation, and the Q statistic was very large
(Q = 7319.1, df = 34, P < 0.0001; I2 = 99.5%).
The results showed high seroprevalence in groups including: direct contact with cats (P < 0.05), eat uncooked meat (P < 0.0001) and











Results of Egger’s regression test indicates publication bias might not have a significant influence on overall prevalence estimate
(P = 0.89).
I2 = 97.85%, P = < 0.001
The highest and lowest seroprevalence of toxoplasmosis were observed in south 53% (95% CI = 30–77) and east 33% (95% CI = 23–
42%), respectively.
Correlation between toxoplasmosis and two risk factors including ‘‘residence (P = 0.005)” and ‘‘contact with cat (P = 0.002)” was











Seroperevalance of toxoplasmosis in different parts of Iran was between 19.3% and 56.4%.
Though the results of this study indicate relatively high prevalence but this does not mean active infection. Also this does not lead to
a conclusion that blood donation screening is required.
Animal intermediate host











There was a wide variation in the cattle toxoplasmosis prevalence among different studies (Q statistic = 1982.9, df = 19, P < 0.0001)
and I2 = 99%.
Rate of toxoplasmosis in different parts of Iran was between 1.4% and 71.3%.













Different studies showed a wide variation in prevalence of toxoplasmosis and the Q statistics was 1189.544882 (df = 33), P < 0.0001,
and I2 = 97.2%.
There was no significant difference in rate of toxoplasmosis between male and female sheep (odds ratio (OR) = 1.002, 95% CI = 0.59–
1.696).











Different studies showed a wide variation in prevalence of toxoplasmosis in goats and the Q statistics was 1172.891557 (df = 15),
P < 0.0001, and I2 = 98.7%.
























































































































































































































































































































































































































































































































































M. Foroutan et al. / Alexandria Journal of Medicine 54 (2018) 189–196 193has been assigned 41% (95% CI = 36–45). Congenital cases appear
more frequently when infection occurs late in pregnancy causing
drastic imperfections of eyes and hearing apparatus. However
debilitating outcomes such as mental retardation, deafness,
retinochoroiditis, microcephaly, and hydrocephaly mostly take
place when infection is encountered in the first trimester. In this
case there are plenty of documentations worldwide.6,10,13 Totally,
seroprevalence rates of toxoplasmosis in pregnant women and
those in childbearing age illustrated more endemicity in the Amer-
icas and Africa, ranging 6.1–77.5% and 25.3–75.2%, respectively.
Additionally, in Europe and Asia the seroprevalence trend indicate
a range scope between 8.2–63.2% and 0.8–63.9%, respectively.30
Moreover, in recent systematic review, annual incidence of con-
genital toxoplasmosis was reported 190,100 cases (95%
CI = 179,300–206,300) from global perspective that impose 1.20
million DALYs (Disability-adjusted life year) (95% CI = 0.76–1.90).
South America, some Middle Eastern and low-income countries
had the highest burden of infection.6 Higher endemicity of toxo-
plasmosis in some regions implicates lower primary active infec-
tion in gestation period, since pregnant women have
encountered T. gondii during their childhood or childbearing age,
leading to the premunition or concomitant immunity in person’s
body which extinguishes the pathogenicity of parasites.6
The other at risk group for toxoplasmosis is immunocompro-
mised patients. So prevalence of infection is significantly higher
in immunocompromised individuals than normal people (50% vs.
39%).2,5 This may be to a great extent due to a relapse originating
from the decline of concomitant immunity in persons with a latent
Toxoplasma infection. The weighted overall seroprevalence of
infection in Iranian immunocompromised patients was 50% (95%
CI = 44–56). Of this, transplant patients were the most exposed risk
group (55%) and AIDS patients (50%) followed by cancer patients
(45%) (Table 1). Corresponding to our finding, in China, a remark-
able difference was found in cancer patients, representing 20.59%
infection seroprevalence compared to the 6.31% in immunocompe-
tent population (P < 0.001; OR 3.90).11 In contrast to infected
immunocompetent individuals which are often asymptomatic,
toxoplasmosis inflicts awful consequences in persons with disor-
dered immune system particularly in AIDS patients, such as infec-
tion reactivation and recrudescence, fulminant disease,
pneumonitis, myocarditis, encephalitis and even death.5,11,12 Fur-
thermore, Toxoplasma serologic diagnosis is faced with the obstacle
of low immune function in immunosuppressed patients and choos-
ing the best diagnostic method is open to question.36
The risk of transmission of Toxoplasma infection by blood trans-
fusion from seemingly asymptomatic and healthy individuals who
are carrier of infection puts an extra burden on global population
especially where toxoplasmosis is more common. Toxoplasma
seropositive individuals in acute stage of infection may have
played a role in transfusion transmitted toxoplasmosis. Africa
and Asia enclosed the highest and lowest global burdens of toxo-
plasmosis in blood donors with prevalence rate of 46% (95%
CI = 14–78) and 29% (95% CI = 23–35), respectively.1 Brazil (75%)
and Ethiopia (73%) had the highest seroprevalence of toxoplasmo-
sis.37,38 The prevalence of toxoplasmosis in Iranian blood donors is
33% (95% CI = 24–42) (Table 1); while lower prevalence was
reported by Galvan-Ramirez et al.,35 in Mexico 17% (95% CI = 15–
19). Blood products are often required in thalassemia patients, tis-
sue graft recipients, individuals suffering from anemia as well as
hematopoietic disorders. Besides, blood transfusion is a vital need
during many operations and surgeries. So allogenic (homologous)
blood transfusion may be associated with the high risk of post-
operative infectious complications.39–41 Some complications have
been reported following donation of Toxoplasma-infected blood
such as reactivation of toxoplasmosis in immunocompromised
patients (HIV+, transplant individuals) receiving allogenic grafts
Table 2
Subgroup analysis for comparison of prevalence in different hosts.
Host No. of studies Prevalence 95% CI I2% Heterogeneity test Egger test
Q P t P
Human intermediate host 6 43 (38–47) 57.5 11.77 0.038 0.84 0.45
Animal intermediate hosts 3 26 (17–35) 69 6.45 0.040 0.88 0.54
Definitive host 1 34 (22–46) – – – – –
Overall 10 37 (31–43) 81.9 49.62 <0.001 0.04 0.97
Test for heterogeneity between sub-groups:
Q: 13.15; P-value: 0.001.
194 M. Foroutan et al. / Alexandria Journal of Medicine 54 (2018) 189–196particularly suffering from graft-versus-host disease (GVHD) as
well as high mortality in cord blood transplantation cases with dis-
seminated toxoplasmosis.42,43 According to WHO recommenda-
tions, screening of donated blood for transfusion-transmitted
infections must be performed for human immunodeficiency virus
(HIV), hepatitis B virus surface antigen (HBsAg), hepatitis C virus
(HCV) and Treponema pallidum (causative agent of Syphilis) in all
countries. Furthermore, blood screening tests have to be accom-
plished for Malaria, Chagas disease, human T-cell lymphotropic
viruses I/II (HTLV I/II) and human cytomegalovirus (CMV) in some
countries and endemic regions.44 In this case, a pre-transfusion
screening for T. gondii has not yet been considered; therefore,
afore-mentioned groups constitute highly susceptible populations
which are predisposed to acute and severe toxoplasmosis by
donated bloods. According to Siegel et al. (1971)45 study, transmis-
sion of parasites through leukocytes transfusion from donors
infected to chronic myelogenous leukemia (CML) was documented.
Additionally, they showed that the parasite survives in citrated
blood condition at 5 C up to 50 days, thus prevention of disease
transmission could not be accomplished by refrigeration of blood
packs during storage period. The same route of infection was
implied by Roth et al. (1971).46 Also a weird case of acquired
retinochoroiditis resulting from toxoplasmosis was reported with
platelet transfusion as its possible reason.47 Nevertheless, based
on data from American Association of Blood Banks, transfusion-
transmitted toxoplasmosis categorizes as rare (www.aabb.org/
tm/eid/Documents/227s.pdf). In our previous systematic review
of toxoplasmosis in Iranian blood donors based on molecular
methods, only in a low proportion of IgM+ samples the parasite
DNA was identified.1 This finding suggests high serologic preva-
lence does not justify donor screening, for two reasons: (1) serol-
ogy does not imply infectivity; and (2) a high serologic
background prevalence (if used to eliminate donors) would result
in major limitation on blood availability; thus, causing more harm
than toxoplasmosis. It seems a test for the direct presence of the
organism in blood (an antigen test or a DNA based test) will be use-
ful. Ideally, provide a method to inactivate Toxoplasma infection in
blood products. However, for better understanding of this issue,
more studies should be designed using molecular techniques in
the future.
Toxoplasmosis is recognized as a likely reason of stillbirth,
abortion and fetal mummification in small ruminants such as
sheep and goat, causing detriments to animal husbandry and sub-
stantial economic losses.48 The risk of human infection is always
lurking around in regions that people consume mutton, goat and
calf meat regularly.7,49 Toxoplasma has also been found in milk of
host animals. Despite of mandatory pasteurization procedure in
milk processing industries that kills T. gondii, there have been some
reports indicative of transmission of infection by raw goat milk and
its derivatives such as whey and cheese to humans and pigs, lead-
ing to health problems and even serious symptoms.50–53 Among
common food animals in Iran, the highest prevalence was dedi-
cated to sheep with 31% (95% CI = 26–35), followed by goats with
27% (95% CI = 14–42) and cattle with 18% (95% CI = 10–28)(Table 1). Cats which devour on Toxoplasma-infected rodents, pass
large amounts of oocysts and implicate a pivotal role in disease
transmission. The prevalence rate of toxoplasmosis in cats of Iran
was 34% (95% CI = 22–46.) (Table 1). This relatively high prevalence
probably originates from several factors such as lack of routine
treatment, significant exuberance of feline hosts and favorable
humid climate.23 In Ethiopia small ruminants and cat populations
were appointed prevalence rates of 35% (95% CI = 21–51) and 88%
(95% CI = 79–93), respectively.28 Up to 59% of sheep and 92% of
goats in Brazil had antibodies against T. gondii.29 In Iran, there exist
several molecular studies on the prevalence of infection in meat
and meat products of food animals which emphasize the danger
of food-transmitted toxoplasmosis.54–58 Also, individuals who are
in direct contact with raw meat especially veterinarians, butchers
and slaughterhouse staff, have been shown to be more prone to
infection.59,60
In conclusion, this systematic review and meta-analysis
focuses on the distribution and epidemiological aspects of toxo-
plasmosis in Iran. Regarding geographical climate of Iran, toxo-
plasmosis proceed to higher rates in Caspian Sea littoral but
nipping highland provinces as well as hot territories were sub-
stantiated to have lower seroprevalence rates, highlighting the
importance of humidity and adequate temperature for oocyst
survival and infectivity. Public awareness, training courses and
hygienic practice all are valuable to direct people toward cooked
meat, washed vegetables, organizing stray cats as well as on
time and proper treatment of infected household cats. Intense
surveillance system and regular inspection in food production
industries, improved hygienic criteria in abattoirs and sanitary
disposal of viscera in addition to advanced screening programs
using a modulus diagnostic assay particularly in two risk groups
in endemic regions, i.e. immunocompromised patients and preg-
nant women, are very important to harness transmission cycle of
the parasite. Although there have been comprehensive and ana-
lytical studies on the prevalence of T. gondii infection in general
population, blood donors, women in pregnancy and childbearing
age, immunocompromised patients and animals such as sheep,
goat, cattle, and cat in Iran, there is lack of systematic reviews
and meta-analysis about toxoplasmosis in consumed meats as
well as birds and other hosts of zoonotic potential in the coun-
try. We propose to pay more attention on the above-mentioned
neglected groups by researchers in future.Compliance with ethical standards
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